For Doctors in a Hurry
- The interplay between periventricular white matter hyperintensities (lesions indicating vascular damage) and glucose hypometabolism in beta-amyloid-negative cognitive impairment remains unclear.
- Researchers conducted a retrospective cross-sectional study of 141 beta-amyloid-negative patients with mild cognitive impairment and 83 normal controls.
- Greater periventricular lesion burden correlated with lower glucose uptake, strongest in the posterior cingulate cortex (beta = -0.14; 95% confidence interval -0.20 to -0.09).
- Cortical hypometabolism mediated the effect of these lesions on executive dysfunction, whereas memory dysfunction was directly driven by the white matter lesions.
- Combining positron emission tomography with MRI could improve diagnostic and therapeutic stratification for patients with vascular cognitive impairment.
The Vascular Toll on the Aging Brain
White matter hyperintensities are ubiquitous findings on brain magnetic resonance imaging in older adults that frequently signal underlying cerebral small vessel disease, a condition where the pooled prevalence of global cognitive impairment reaches 57% [1]. These lesions elevate the risk for stroke, cognitive decline, and mortality, with severe burdens strongly associated with vascular dementia (odds ratio 10.35) [2, 1]. In patients with mild cognitive impairment, a higher volume of these vascular lesions consistently correlates with worse cognitive performance, particularly in attention and executive functioning (effect size -0.26) [3]. Furthermore, longitudinal data indicate that white matter hyperintensity volume significantly increases the risk of progressing from normal cognition to mild cognitive impairment by 35% (relative risk 1.35) and to frank dementia by 49% (relative risk 1.49) [4]. While the link between structural white matter damage and cognitive impairment is well established, the exact mechanisms by which these vascular lesions disrupt downstream cortical networks remain incompletely understood. Recent findings now provide specific data on how regional white matter lesions interact with cortical glucose metabolism to drive distinct cognitive deficits in patients lacking the beta-amyloid pathology characteristic of Alzheimer disease.
Both periventricular white matter hyperintensities (PWMHs) and regional brain glucose hypometabolism have been linked to cognitive impairment in older adults. However, the interplay between these structural lesions and metabolic deficits independent of beta-amyloid is unclear, leaving a gap in understanding how vascular damage affects brain function in the absence of Alzheimer disease pathology. To address this clinical question, researchers examined whether PWMHs relate to region-specific cortical hypometabolism in amyloid-negative individuals. The study also evaluated whether this metabolic suppression mediates domain-specific cognitive decline, aiming to clarify if structural lesions directly cause cognitive deficits or if they operate indirectly by depressing regional brain metabolism.
The researchers utilized a retrospective cross-sectional design to evaluate a clinical cohort from Severance Hospital at Yonsei University between 2017 and 2022. The study included 141 amyloid-negative patients with mild cognitive impairment older than 50 years, alongside 83 normal controls. Baseline demographic comparisons confirmed that the mild cognitive impairment and normal control groups did not differ in age or sex. All participants underwent 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET), magnetic resonance imaging (MRI), and comprehensive cognitive testing.
To quantify the structural vascular burden, PWMHs were defined as white matter hyperintensities within 10 millimeters of the lateral ventricles on MRI. To measure corresponding metabolic function, the researchers extracted regional FDG standardized uptake value ratios (a metric that quantifies the concentration of the radiotracer in specific brain tissues to assess local glucose metabolism) from predefined cortical and limbic regions. The researchers then mapped the relationships between these structural and metabolic variables and clinical symptoms using general linear models and path analyses (a statistical method used to evaluate directed dependencies among a set of variables to determine direct versus indirect effects).
The structural damage caused by periventricular white matter hyperintensities demonstrated a clear negative impact on brain metabolism. Specifically, the researchers found that a greater periventricular lesion burden correlated with lower FDG uptake across the brain. This metabolic suppression was not uniform. The correlation between lesion burden and lower FDG uptake was strongest in the posterior cingulate cortex (β = -0.14; 95% CI -0.20 to -0.09; q < 0.001), a central node for memory and default mode network function. For clinicians, this indicates that vascular damage near the ventricles is tightly linked to reduced metabolic activity in distant cortical regions critical for cognitive processing.
Beyond metabolic changes, the structural burden of these periventricular lesions translated directly into measurable cognitive deficits across multiple domains. The analysis revealed that periventricular white matter hyperintensities were related to lower executive scores (β = -0.41; 95% CI -0.74 to -0.08; q = 0.026), reflecting an impaired ability to plan, focus attention, and manage multiple tasks. Furthermore, the lesions significantly impacted memory retention and recall. The researchers documented that the lesions were related to lower verbal memory scores (β = -0.73; 95% CI -1.16 to -0.30; q = 0.005) as well as lower visual memory scores (β = -0.62; 95% CI -1.01 to -0.23; q = 0.005). These specific statistical associations underscore how periventricular vascular damage broadly compromises a patient's cognitive profile, affecting both executive function and distinct memory pathways.
Divergent Pathways for Executive and Memory Dysfunction
To understand the mechanisms driving these cognitive deficits, the researchers utilized path analyses to map the relationships between structural lesions, regional metabolism, and clinical symptoms. The analysis revealed that the effect of periventricular white matter hyperintensities on executive dysfunction was mediated by cortical hypometabolism. Specifically, the models indicated indirect effects of the lesions on executive function through hypometabolism in the frontal lobe (indirect β = -0.06; 95% CI -0.13 to -0.01; p = 0.016). Furthermore, the data showed indirect effects on executive function through hypometabolism in the posterior cingulate cortex (β = -0.12; 95% CI -0.20 to -0.04; p = 0.003). For clinicians, this indicates that structural vascular damage near the ventricles does not impair executive function on its own, but rather disrupts downstream metabolic activity in the frontal lobe and posterior cingulate cortex, which in turn compromises executive capabilities.
In contrast to the indirect metabolic pathway driving executive deficits, the researchers found that memory dysfunction was directly driven by periventricular white matter hyperintensities. The statistical models demonstrated that structural lesions impaired memory independently of regional glucose metabolism. Direct effects of the lesions were identified for verbal memory (β = -0.27; 95% CI -0.45 to -0.08; p = 0.006). Similarly, direct effects were identified for visual memory (β = -0.24; 95% CI -0.41 to -0.08; p = 0.005). Because vascular lesions impair distinct cognitive domains through these divergent mechanisms, structural imaging alone may not capture the full pathophysiological picture. Consequently, the findings suggest that incorporating 18F-FDG PET with MRI may enhance diagnostic and therapeutic stratification in clinical trials for vascular cognitive impairment. By combining metabolic and structural imaging, physicians can better identify which patients are experiencing direct structural memory deficits versus indirect metabolic executive dysfunction, potentially guiding more targeted interventions in the future.
References
1. Jin C, Beran RG, Bhaskar SMM. Neuroimaging and Genetic Markers of Cerebral Small Vessel Disease and Cognitive Outcomes: A Systematic Review and Meta-Analysis (NEUROGEN-SVD Study). Diagnostics. 2025. doi:10.3390/diagnostics15202585
2. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010. doi:10.1136/bmj.c3666
3. Berg EVD, Geerlings MI, Biessels GJ, Nederkoorn PJ, Kloppenborg RP. White Matter Hyperintensities and Cognition in Mild Cognitive Impairment and Alzheimer's Disease: A Domain-Specific Meta-Analysis.. Journal of Alzheimer's disease : JAD. 2018. doi:10.3233/JAD-170573
4. Guo W, Shi J. White matter hyperintensities volume and cognition: A meta-analysis.. Frontiers in aging neuroscience. 2022. doi:10.3389/fnagi.2022.949763
